Get the Stockscreener App
1.80
1.64%
-0.03
After Hours:
1.80
Cognition Therapeutics Inc stock is traded at $1.80, with a volume of 1.61M.
It is down -1.64% in the last 24 hours and down -17.05% over the past month.
Cognition Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of, small-molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its product candidate CT1812, is an orally delivered, small-molecule antagonist designed to penetrate the blood-brain barrier and bind selectively to the S2R complex.
See More
Previous Close:
$1.83
Open:
$1.86
24h Volume:
1.61M
Relative Volume:
0.26
Market Cap:
$132.34M
Revenue:
-
Net Income/Loss:
$-22.83M
P/E Ratio:
-2.2785
EPS:
-0.79
Net Cash Flow:
$-20.87M
1W Performance:
+16.88%
1M Performance:
-17.05%
6M Performance:
+410.06%
1Y Performance:
+349.66%
1-Day Range:
$1.71
$1.8997
1-Week Range:
$1.48
$2.05
52-Week Range:
$0.2223
$3.83
Cognition Therapeutics Inc Stock (CGTX) Company Profile
Name
Cognition Therapeutics Inc
Sector
Industry
Phone
412-481-2210
Address
2403 SIDNEY STREET, PITTSBURGH
Compare CGTX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CGTX
Cognition Therapeutics Inc
|
1.80 | 161.45M | 0 | -22.83M | -20.87M | -0.79 |
|
VRTX
Vertex Pharmaceuticals Inc
|
407.37 | 104.55B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
464.95 | 60.36B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
557.73 | 59.84B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
799.56 | 49.07B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
327.03 | 35.16B | 4.56B | -176.77M | 225.30M | -1.7177 |
Cognition Therapeutics Inc Stock (CGTX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-19-24 | Upgrade | B. Riley Securities | Neutral → Buy |
| Jul-30-24 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| Nov-03-21 | Initiated | B. Riley Securities | Buy |
| Nov-03-21 | Initiated | Oppenheimer | Outperform |
Cognition Therapeutics Inc Stock (CGTX) Latest News
Visual analytics tools that track Cognition Therapeutics Inc. performanceJuly 2025 WrapUp & Expert Curated Trade Setup Alerts - newser.com
Why Cognition Therapeutics Inc. stock appeals to dividend seekers2025 Top Gainers & AI Enhanced Trading Alerts - newser.com
Will Cognition Therapeutics Inc. stock benefit from commodity prices2025 Market Sentiment & AI Driven Stock Movement Reports - newser.com
Smart tools for monitoring Cognition Therapeutics Inc.’s price actionPortfolio Value Report & Daily Technical Stock Forecast Reports - newser.com
Can swing trading help recover from Cognition Therapeutics Inc. lossesMarket Activity Summary & Fast Moving Market Watchlists - newser.com
Cognition Therapeutics, Inc.Common Stock (NQ: - FinancialContent
Is it too late to sell Cognition Therapeutics Inc.Quarterly Trade Report & High Win Rate Trade Tips - newser.com
Cognition Therapeutics' (CGTX) "Sell (E+)" Rating Reaffirmed at Weiss Ratings - MarketBeat
Evaluating Cognition Therapeutics Inc. with trendline analysisTrade Performance Summary & Low Drawdown Investment Ideas - newser.com
Is Cognition Therapeutics Inc. showing signs of accumulationQuarterly Earnings Report & Low Risk High Reward Trade Ideas - newser.com
Pattern recognition hints at Cognition Therapeutics Inc. upsideMarket Growth Review & Pattern Based Trade Signal System - newser.com
Cognition Therapeutics (CGTX) Moves to Buy: Rationale Behind the Upgrade - sharewise.com
Cognition Therapeutics (NASDAQ:CGTX) Stock Price Up 13.6%Still a Buy? - MarketBeat
Will Cognition Therapeutics Inc. benefit from macro trendsMarket Performance Recap & Risk Controlled Swing Trade Alerts - newser.com
How hedge fund analytics apply to Cognition Therapeutics Inc. stock2025 AllTime Highs & Verified Momentum Stock Alerts - newser.com
Has Cognition Therapeutics Inc. found a price floor2025 AllTime Highs & Reliable Intraday Trade Alerts - newser.com
Analyzing drawdowns of Cognition Therapeutics Inc. with statistical toolsWeekly Trend Recap & AI Driven Stock Movement Reports - newser.com
Is it time to cut losses on Cognition Therapeutics Inc.2025 Performance Recap & AI Driven Stock Reports - newser.com
Has Cognition Therapeutics Inc. formed a bullish divergenceQuarterly Market Summary & Daily Oversold Stock Bounce Ideas - newser.com
Does Cognition Therapeutics Inc. stock trade at a discount to peersWeekly Investment Recap & Capital Efficient Trading Techniques - newser.com
Is Cognition Therapeutics Inc. stock entering bullish territoryJuly 2025 Outlook & Weekly Top Gainers Alerts - newser.com
Can Cognition Therapeutics Inc. stock hit record highs againEarnings Risk Report & Verified Trade Idea Suggestions - newser.com
Cognition Therapeutics, Inc. (NASDAQ:CGTX) Receives Consensus Recommendation of "Moderate Buy" from Brokerages - MarketBeat
Chart based analysis of Cognition Therapeutics Inc. trends2025 Big Picture & Short-Term High Return Strategies - newser.com
What drives Cognition Therapeutics Inc stock priceStock Split Announcements & Budget Friendly Trading Ideas - earlytimes.in
Published on: 2025-09-29 01:45:20 - newser.com
Cognition Therapeutics Inc Stock (CGTX) Financials Data
Revenue
Net Income
Cash Flow
EPS
Cognition Therapeutics Inc Stock (CGTX) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Ricciardi Lisa | CEO & President |
Jan 31 '25 |
Buy |
0.77 |
38,851 |
30,001 |
38,851 |
1.11%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):